Bausch Health [BHC] vs Alkermes plc [ALKS] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Bausch Health Companies Inc. wins in 12 metrics, Alkermes plc wins in 8 metrics, with 0 ties. Bausch Health Companies Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Bausch Health Companies Inc. | Alkermes plc | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 13.19 | 23.71 | Bausch Health Companies Inc. |
| Price-to-Book Ratio | 5.58 | 3.09 | Alkermes plc |
| Debt-to-Equity Ratio | 5,591.25 | 3.85 | Alkermes plc |
| PEG Ratio | -0.06 | -0.36 | Bausch Health Companies Inc. |
| EV/EBITDA | 6.69 | 18.26 | Bausch Health Companies Inc. |
| Profit Margin (TTM) | 1.53% | 16.37% | Alkermes plc |
| Operating Margin (TTM) | 25.79% | 15.11% | Bausch Health Companies Inc. |
| EBITDA Margin (TTM) | 25.79% | 15.11% | Bausch Health Companies Inc. |
| Return on Equity | 436.36% | 14.72% | Bausch Health Companies Inc. |
| Return on Assets (TTM) | 5.18% | 6.99% | Alkermes plc |
| Free Cash Flow (TTM) | $993.00M | $480.33M | Bausch Health Companies Inc. |
| 1-Year Return | -15.38% | 48.44% | Alkermes plc |
| Price-to-Sales Ratio (TTM) | 0.20 | 3.83 | Bausch Health Companies Inc. |
| Enterprise Value | $22.75B | $5.13B | Bausch Health Companies Inc. |
| EV/Revenue Ratio | 2.22 | 3.48 | Bausch Health Companies Inc. |
| Gross Profit Margin (TTM) | 71.46% | 87.98% | Alkermes plc |
| Revenue per Share (TTM) | $28 | $9 | Bausch Health Companies Inc. |
| Earnings per Share (Diluted) | $0.42 | $1.43 | Alkermes plc |
| Beta (Stock Volatility) | 0.40 | 0.39 | Alkermes plc |
| Short % of Float | 2.00% | 15.90% | Bausch Health Companies Inc. |
Bausch Health Companies Inc. vs Alkermes plc Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Bausch Health Companies Inc. | -1.38% | -2.35% | -7.93% | -0.80% | -27.79% | -30.79% |
| Alkermes plc | 0.18% | 4.50% | 18.36% | 58.43% | 57.47% | 56.97% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Bausch Health Companies Inc. | -15.38% | -31.16% | -82.74% | -77.04% | -89.99% | -77.64% |
| Alkermes plc | 48.44% | 37.56% | 81.33% | 7.03% | 166.59% | 137.55% |
Performance & Financial Health Analysis: Bausch Health Companies Inc. vs Alkermes plc
| Metric | BHC | ALKS |
|---|---|---|
| Market Information | ||
| Market Cap | $2.10B | $5.55B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,154,689 | 1,637,141 |
| 90 Day Avg. Volume | 1,376,966 | 2,593,004 |
| Last Close | $4.99 | $44.36 |
| 52 Week Range | $4.93 - $8.69 | $25.17 - $45.76 |
| % from 52W High | -42.58% | -3.06% |
| All-Time High | $263.81 (Aug 03, 2015) | $98.50 (Feb 28, 2000) |
| % from All-Time High | -98.11% | -54.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.09% | -0.11% |
| Quarterly Earnings Growth | N/A | -0.66% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 0.16% |
| Operating Margin (TTM) | 0.26% | 0.15% |
| Return on Equity (TTM) | 4.36% | 0.15% |
| Debt to Equity (MRQ) | 5,591.25 | 3.85 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-1.50 | $10.99 |
| Cash per Share (MRQ) | $3.53 | $3.53 |
| Operating Cash Flow (TTM) | $1.40B | $520.75M |
| Levered Free Cash Flow (TTM) | $1.09B | $-363,090,624 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Bausch Health Companies Inc. vs Alkermes plc
| Metric | BHC (Apr 26, 2026) | ALKS (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 13.19 | 23.71 |
| Forward P/E | 1.37 | 48.44 |
| PEG Ratio | -0.06 | -0.36 |
| Price to Sales (TTM) | 0.20 | 3.83 |
| Price to Book (MRQ) | 5.58 | 3.09 |
| Market Capitalization | ||
| Market Capitalization | $2.10B | $5.55B |
| Enterprise Value | $22.75B | $5.13B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.22 | 3.48 |
| Enterprise to EBITDA | 6.69 | 18.26 |
| Risk & Other Metrics | ||
| Beta | 0.40 | 0.39 |
| Book Value per Share (MRQ) | $-1.50 | $10.99 |
Financial Statements Comparison: Bausch Health Companies Inc. vs Alkermes plc
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | BHC (2025) | ALKS (2025) |
|---|---|---|
| Revenue/Sales | 10.27B | 1.48B |
| Cost of Goods Sold | 3.01B | 196.46M |
| COGS % of Revenue | 29.3% | 13.3% |
| Gross Profit | 7.25B | 1.28B |
| Gross Margin | 70.7% | 86.7% |
| Research & Development | 629.00M | 323.96M |
| Operating Income (EBIT) | 2.19B | 253.96M |
| Operating Margin | 21.3% | 17.2% |
| EBITDA | 3.44B | 330.89M |
| EBITDA Margin | 33.5% | 22.4% |
| Pre-Tax Income | 367.00M | 291.45M |
| Pre-Tax Income % of Revenue | 3.6% | 19.7% |
| Income Tax | 247.00M | 49.79M |
| Income Tax % of Revenue | 2.4% | 3.4% |
| Net Income (Profit) | 120.00M | 241.66M |
| Profit Margin | 1.2% | 16.4% |
Balance Sheet & Liquidity Metrics
| Metric | BHC (2025) | ALKS (2025) |
|---|---|---|
| Cash & Equivalents | 1.31B | 388.57M |
| Total Current Assets | 6.16B | 1.93B |
| Total Current Assets % of Revenue | 60.0% | 130.7% |
| Total Current Liabilities | 4.18B | 543.44M |
| Total Current Liabilities % of Revenue | 40.7% | 36.8% |
| Long-Term Debt | 20.62B | 63.25M |
| Long-Term Debt % of Revenue | 200.8% | 4.3% |
| Total Shareholders Equity | 377.00M | 1.82B |
| Retained Earnings | -9.67B | -734.79M |
| Retained Earnings % of Revenue | -94.2% | -49.8% |
| Property, Plant & Equipment | 112.00M | 77.21M |
Cash Flow Statement Comparison
| Metric | BHC (2025) | ALKS (2025) |
|---|---|---|
| Operating Cash Flow | 1.36B | 545.23M |
| Operating Cash Flow % of Revenue | 13.3% | 36.9% |
| Capital Expenditures | -397.00M | -39.33M |
| Free Cash Flow | 993.00M | 480.33M |
| FCF Margin | 9.7% | 32.5% |
| Debt Repayment | -11.19B | 0 |
| Common Stock Repurchase | N/A | 0 |
Short Interest & Institutional Ownership Analysis
| Metric | BHC | ALKS |
|---|---|---|
| Shares Short | 5.99M | 19.01M |
| Short Ratio | 2.67 | 7.03 |
| Short % of Float | 2.00% | 15.90% |
| Shares Outstanding | 370.53M | 165.61M |
| Float Shares | 258.52M | 154.04M |
| % Held by Insiders | 30.41% | 1.42% |
| % Held by Institutions | 65.20% | 110.87% |
| % Held by Public | 4.39% | -12.29% |
Dividend Analysis & Yield Comparison: Bausch Health Companies Inc. vs Alkermes plc
| Metric | BHC | ALKS |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | $0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |